Steve Goedeke

Steve Goedeke is the President and CEO of Cardionomic, a medical technology company focused on developing neuromodulation therapies for heart failure. He has held this position since December 2012 and is based in New Brighton, Minnesota. Under his leadership, Cardionomic has garnered support from prominent investors, including NEA, Ascension, Integer, and the Cleveland Clinic.12

Professional Background

Goedeke's career spans over three decades in the medical device industry. Before joining Cardionomic, he was the President and CEO of Denali Medical II, where he successfully advanced Cardionomic through multiple funding rounds after licensing it from the Cleveland Clinic.12 His earlier roles include significant positions at Medtronic, where he served as a Senior Director in various capacities related to cardiac rhythm management and electronic systems design. Notably, he played a crucial role in developing the Medical Implant Communication System (MICS) and has received multiple awards for his contributions to the field.23

Education

Steve Goedeke holds a Bachelor of Science in Electrical Engineering from Washington University in St. Louis and a Master of Science in Electrical Engineering from the University of Illinois at Urbana-Champaign.12

Achievements

Throughout his career, Goedeke has been recognized for his innovative contributions to medical technology, holding 25 patents related to his work.2 He is also a Bakken Fellow and has received Medtronic's Star of Excellence and The Chairman’s Award for Outstanding Initiative.2

In summary, Steve Goedeke is a seasoned executive with extensive experience in medical devices and technology development, particularly in cardiac care.